I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 3 studies | 29% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 3 studies | 29% ± 9% |
Insufficient scRNA-seq data for expression of ENO3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 4425.38 | 226 / 226 | 94% | 19.14 | 380 / 406 |
| thymus | 85% | 910.10 | 553 / 653 | 92% | 14.68 | 559 / 605 |
| kidney | 85% | 769.24 | 76 / 89 | 69% | 5.39 | 625 / 901 |
| uterus | 59% | 434.82 | 100 / 170 | 80% | 11.52 | 368 / 459 |
| prostate | 64% | 933.31 | 157 / 245 | 72% | 5.32 | 361 / 502 |
| lung | 68% | 469.36 | 393 / 578 | 66% | 6.38 | 760 / 1155 |
| intestine | 67% | 527.97 | 644 / 966 | 67% | 2.71 | 353 / 527 |
| ovary | 43% | 291.52 | 77 / 180 | 80% | 4.11 | 346 / 430 |
| breast | 42% | 354.25 | 191 / 459 | 74% | 3.95 | 824 / 1118 |
| brain | 13% | 119.59 | 346 / 2642 | 87% | 4.66 | 616 / 705 |
| muscle | 100% | 202457.73 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.74 | 1 / 1 |
| heart | 100% | 15639.67 | 857 / 861 | 0% | 0 | 0 / 0 |
| bladder | 38% | 285.48 | 8 / 21 | 61% | 3.86 | 305 / 504 |
| skin | 11% | 148.81 | 205 / 1809 | 86% | 6.64 | 405 / 472 |
| spleen | 97% | 897.41 | 233 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 36.74 | 75 / 80 |
| esophagus | 37% | 372.54 | 541 / 1445 | 55% | 2.13 | 100 / 183 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 7.49 | 26 / 29 |
| stomach | 22% | 126.89 | 78 / 359 | 63% | 2.48 | 181 / 286 |
| pancreas | 5% | 30.61 | 17 / 328 | 69% | 2.48 | 123 / 178 |
| adrenal gland | 36% | 228.07 | 92 / 258 | 33% | 1.54 | 77 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 64% | 15.82 | 29 / 45 |
| peripheral blood | 46% | 752.37 | 424 / 929 | 0% | 0 | 0 / 0 |
| adipose | 36% | 251.88 | 439 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 33% | 319.85 | 437 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0061621 | Biological process | canonical glycolysis |
| GO_0006094 | Biological process | gluconeogenesis |
| GO_0006096 | Biological process | glycolytic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0000015 | Cellular component | phosphopyruvate hydratase complex |
| GO_0004634 | Molecular function | phosphopyruvate hydratase activity |
| GO_0000287 | Molecular function | magnesium ion binding |
| Gene name | ENO3 |
| Protein name | phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (Skeletal muscle enolase) Enolase 3 Enolase 3 (Muscle-specific enolase) (Skeletal muscle enolase) Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase) |
| Synonyms | |
| Description | FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Appears to have a function in striated muscle development and regeneration. . FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Appears to have a function in striated muscle development and regeneration. . FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Appears to have a function in striated muscle development and regeneration. . FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Appears to have a function in striated muscle development and regeneration. . FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Appears to have a function in striated muscle development and regeneration. . FUNCTION: Glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. Appears to have a function in striated muscle development and regeneration. . |
| Accessions | K7EKN2 E5RI09 ENST00000522249.5 K7EP84 ENST00000519602.6 [P13929-1] E5RJH5 ENST00000518175.1 [P13929-1] ENST00000522798.5 E5RGZ4 ENST00000519266.5 ENST00000519602 ENST00000521811.5 ENST00000521659.5 ENST00000522301.5 ENST00000519584.5 [P13929-3] ENST00000520221.5 ENST00000323997.10 [P13929-1] E5RG95 K7EPM1 P13929 |
